Source: OnecLive, July 2019 Transcript: Jeffrey S. Weber, MD, PhD: OK. So the patient then goes to the surgeon. They also go to the medical oncologist. Hussein, what kind of testing…
Source: OncLive, July 2019 Ryan J. Sullivan, MD, associate director, Melanoma Program, Massachusetts General Hospital Cancer Center, discusses the results of the COMBI-d and COMBI-v studies, led to changes in…
Source: OnClive, July 2019 Transcript: Ryan J. Sullivan, MD: The only way you ever know if one regimen is better than another is to compare them head to head. In the…
Source: OnClive, July 2019 Transcript: Geoffrey Thomas Gibney, MD: In patients with BRAF-mutated melanoma, as well as melanoma in general that is advanced and unresectable, we’ve made major progress in the treatment…